ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

Name: ATAI Life Sciences N.V.: Is Infosys Ltd. worth buying?
Item: ATAI Life Sciences N.V.
Rating: 1.84441675
Author: Trendlyne DVM scores

about

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for ...

4.57 0.01 (0.22%)

343.69% Gain from 52W Low

3.1M

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for ATAI Life Sciences N.V. is on 17 Sep 2025 for the purpose of TD Cowen 5(th) Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Su See details

Not Eligible

Expensive Valuation

4.7 / 100

Technically Moderately Bullish

69.1 / 100

1Yr Price target upside is 147%

7 analysts

ATAI Life Sciences NV Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for ...

343.69% Gain from 52W Low

SWOT Analysis

ATAI Life Sciences NV Live Price Chart